Literature DB >> 10903745

Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DN alpha/DO beta heterodimer.

D J Taxman1, D E Cressman, J P Ting.   

Abstract

Class II transcriptional activator (CIITA) is a master regulator of MHC class II genes, including DR, DP, and DQ, and MHC class II-associated genes DM and invariant chain. To determine the repertoire of genes that is regulated by CIITA and to identify uncharacterized CIITA-inducible genes, we used representational difference analysis. Representational difference analysis screens for differentially expressed transcripts. All CIITA-induced genes were MHC class II related. We have identified the alpha subunit, DN alpha, of the class II processing factor DO as an additional CIITA-inducible gene. Northern analysis confirmed that DN alpha is induced by IFN-gamma in 2fTGH fibrosarcoma cells, and CIITA is necessary for high-level expression in B cells. The beta subunit, DO beta, is not inducible in fibrosarcoma cells by IFN-gamma or exogenous CIITA expression. Moreover, in contrast to other class II genes, DO beta expression remains high in the absence of CIITA in B cells. The promoters for DN alpha and DO beta contain the highly conserved WXY motifs, and, like other class II genes, expression of both DN alpha and DO beta requires RFX. These findings demonstrate that both DN alpha and DO beta are regulated by RFX. However, DN alpha is defined for the first time as a CIITA-inducible gene, and DO beta as a MHC class II gene whose expression is independent of CIITA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903745     DOI: 10.4049/jimmunol.165.3.1410

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Class II transactivator: mastering the art of major histocompatibility complex expression.

Authors:  J A Harton; J P Ting
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.

Authors:  Krzysztof Masternak; Walter Reith
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

Review 3.  Novel mechanisms of class II major histocompatibility complex gene regulation.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  The DY genes of the cattle MHC: expression and comparative analysis of an unusual class II MHC gene pair.

Authors:  Keith T Ballingall; Shirley A Ellis; Niall D MacHugh; Stephen D Archibald; Declan J McKeever
Journal:  Immunogenetics       Date:  2004-01-24       Impact factor: 2.846

Review 5.  The expression of HLA-DO (H2-O) in B lymphocytes.

Authors:  Xinjian Chen; Peter E Jensen
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

6.  Role of Sug1, a 19S proteasome ATPase, in the transcription of MHC I and the atypical MHC II molecules, HLA-DM and HLA-DO.

Authors:  Yaritza Inostroza-Nieves; Prasanna Venkatraman; Zarixia Zavala-Ruiz
Journal:  Immunol Lett       Date:  2012-07-04       Impact factor: 3.685

Review 7.  The evolving role of semaphorins and plexins in the immune system: Plexin-A1 regulation of dendritic cell function.

Authors:  Brian P O'Connor; Jenny P-Y Ting
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

8.  Collagen alpha1(I) gene (COL1A1) is repressed by RFX family.

Authors:  Pritam Sengupta; Yong Xu; Lin Wang; Russell Widom; Barbara D Smith
Journal:  J Biol Chem       Date:  2005-03-23       Impact factor: 5.157

9.  Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of HLA-DOA That Have Altered Function.

Authors:  Austin M Graves; Francesca Virdis; Eliot Morrison; Miguel Álvaro-Benito; Aly A Khan; Christian Freund; Tatyana V Golovkina; Lisa K Denzin
Journal:  J Immunol       Date:  2020-07-20       Impact factor: 5.422

10.  Mitogen-activated protein kinase ERK1/2 regulates the class II transactivator.

Authors:  Lilien N Voong; Allison R Slater; Sebila Kratovac; Drew E Cressman
Journal:  J Biol Chem       Date:  2008-02-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.